Merck & Co. Operating Cycle 2011-2026 | MRK

Annual Operating Cycle Merck & Co.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
204	208	199	182	228	229	207	208	208	192	175	179	194	204	198

All numbers in USD currency

Maximum	Minimum	Average
229	175	201

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
218	229	231	205	223	226	190	199	199	-	94	93.2	154	-	204	239	235	-	225	269	225	-	187	213	229	-	197	207	214	-	201	212	-48.8 K	-	30.5 K	160 K	18.1 K	-	9.39 K	296 K	4.13 K	-	25.2 K	6.57 K	5.08 K	-	6.43 K	5.65 K	5.1 K	-	4.43 K	4.93 K	6.61 K	-	4.68 K	13.5 K	-

All numbers in USD currency

Maximum	Minimum	Average
296 K	-48.8 K	12.8 K

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	1.94 K	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	512	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	2.1 K	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Alpine Immune Sciences ALPN	1.73	-	-	$ 2.17 B	USA
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	31.4	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	1.1 K	$ 49.8	-0.86 %	$ 4.48 B	Schweiz
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	349	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	321	$ 31.27	4.37 %	$ 2.08 B	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
Anika Therapeutics ANIK	235	$ 14.72	-	$ 211 M	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Esperion Therapeutics ESPR	99.7	$ 3.15	-	$ 655 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA